This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schriock, E. D. Articles by Buster, J. E. Search for Related Content PubMed PubMed Citation Articles by Schriock, E. D. Articles by Buffington, C. K. Articles by Givens, J. R. Articles by Buster, J. E. Social Bookmarking                   What's this?

Enhanced Post-Receptor Insulin Effects in Women Following Dehydroepiandrosterone Infusion

Cynthia K. Buffington

James R. Givens

John E. Buster

OBJECTIVE: We hypothesized that intravenous dehydroepiandrosterone (DHEA) would de crease insulin resistance in normal and insulin-resistant women.

METHODS: Five insulin-resistant women diagnosed as having polycystic ovaries (PCO) with elevated testosterone and normal dehydroepiandrosterone sulfate (DHEAS) with amenorrhea were recruited. Obese controls (OC) with normal menses and normal testosterone and DHEAS were recruited and matched to each PCO woman for age and weight. The PCO women had a mean testosterone of 3.2 ± 0.4 nmol/L, fasting serum insulin level of 330 ± 55 pmol/L, and DHEAS level of 3.4 ± 1.3 µmol/L. An oral glucose tolerance test (OGTT) was performed at 8 AM after an overnightfast. A DHEA infusion (1 mg/hour for 17 hours) was begun at 6 PM and continued until the completion of the second OGTT performed the following morning at 8 AM. T-lympho cytes were drawn at 8 AM each morning.

RESULTS: The DHEA infusion had no significant effect on any of the in vivo indices of insulin sensitivity, ie, basal and OGTT insulin, C-peptide, and ratios of insulin/glucose. In vitro, DHEA significantly increased insulin binding to T-lymphocytes of PCO women but caused no significant change in OC women. There was, however, marked enhancement of T-lymphocyte pyruvate dehydrogenase (PDH) activities in both groups of study subjects following DHEA.

CONCLUSION: We conclude that a 17-hour infusion of DHEA enhanced T-lymphocyte insulin binding and PDH activity while producing no detectable improvements in in vivo indices of insulin sensitivity. (J Soc Gynecol Invest 1994;1:74-8)

Key Words: DHEA • insulin • polycystic ovary syndrome.

Journal of the Society for Gynecologic Investigation, Vol. 1, No. 1, 74-78 (1994)
DOI: 10.1177/107155769400100115


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?